CONMED
CNMD
155 hedge funds and large institutions have $1.11B invested in CONMED in 2013 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 52 increasing their positions, 64 reducing their positions, and 15 closing their positions.
100% more call options, than puts
Call options by funds: $4K | Put options by funds: $2K
23% more capital invested
Capital invested by funds: $902M → $1.11B (+$205M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 15
1% less funds holding
Funds holding: 157 → 155 (-2)
19% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 64
Top Buyers
Top Sellers
CNMD Hedge Fund Activity: Q4 2013 in Review
155 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q4 2013, worth a combined $1.11B — up 23% from $902M a quarter earlier.
Fund positioning in CNMD was balanced in Q4 2013: 15 funds opened new positions, 15 closed out, 52 added to existing stakes and 64 trimmed.
The largest buyer was Camber Capital Management, adding an estimated $14.6M. The largest seller was Heartland Advisors, cutting an estimated $12.3M.
- 155 institutional investors held CONMED (CNMD) as of Q4 2013, down from 157 in Q3 2013.
- Funds reported $1.11B of CONMED stock for Q4 2013, up 23% quarter-over-quarter.
- 15 funds opened new CONMED positions in Q4 2013 and 15 closed out, a net change of 0 holders.
- The largest CONMED buyer in Q4 2013 was Camber Capital Management, an estimated $14.6M added.
- The largest CONMED seller in Q4 2013 was Heartland Advisors, an estimated $12.3M sold.
Based on aggregated 13F filings for Q4 2013.